This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
COVID-19 Stroke Strokes 
Frontiers in Cardiovascular Medicine
JANUARY 28, 2025
Systematic search conducted without language restrictions from December 1, 2019 to June 31, 2022 on PubMed, EMBASE, Web of Science, Cochrane library, ProQuest Coronavirus Research Database, COVID-19 Living Overview of the Evidence (L-OVE) subset of Episteminokos and the World Health Organization (WHO) Covid-19 databases.
95 
Medical Xpress - Cardiology
OCTOBER 9, 2024
A history of COVID-19 can double the risk of heart attack, stroke or death according to new research led by Cleveland Clinic and the University of Southern California.
145 
American Heart News - Heart News
OCTOBER 9, 2024
Research Highlights: An analysis of UK Biobank health data that included adults who had mild to severe COVID-19 before vaccines were available found an increased risk of heart attack, stroke and death among those adults during the nearly three-year.
145 
Medical Xpress - Cardiology
JANUARY 2, 2025
COVID-19 is a respiratory disease primarily affecting the lungs. However, the SARS-CoV-2 virus that causes COVID-19 surprised doctors and scientists by causing an unusually large percentage of patients to experience vascular complicationsissues related to blood flow, such as blood clots, heart attacks, and strokes.
134 
HCPLive
AUGUST 25, 2024
Moderate to severe anemia was linked to an increase in cardiac arrest or stroke compared with normal hemoglobin levels in critically ill COVID-19 patients.
105 
Medical Xpress - Cardiology
DECEMBER 14, 2023
A large international research collaboration, led by an academic from Royal Holloway, University of London, found that blood groups could help predict the risk of venous strokes associated with the Oxford-AstraZeneca COVID-19 vaccine.
122 
Science Daily - Heart Disease
OCTOBER 9, 2024
An analysis of data in the UK Biobank has found that COVID-19 infection may increase the risk of heart attack, stroke and death from any cause for up to three years for people with and without cardiovascular disease, according to new research.
114 
Medical Xpress - Cardiology
MARCH 21, 2024
For Medicare beneficiaries aged 65 years and older, there is no evidence of elevated stroke risk immediately after vaccination with either brand of the COVID-19 bivalent vaccine, according to a study published in the March 19 issue of the Journal of the American Medical Association.
109 
DAIC
DECEMBER 14, 2023
Ioannis Katsoularis, image courtesy of Klas Sjöberg milla1cf Thu, 12/14/2023 - 09:23 December 14, 2023 — Individuals infected with COVID-19 are also at an increased risk of suffering from heart rhythm disturbances, such as atrial fibrillation. We could also see that unvaccinated people were at higher risk than vaccinated people.
111 
Med Page Today
MARCH 19, 2024
(MedPage Today) -- Investigation of an early signal for stroke associated with COVID-19 bivalent vaccines turned into suspicion of high-dose or adjuvanted flu shots instead, based on a large U.S. population-based study. When researchers inspected.
142 
DAIC
MARCH 20, 2024
Getty Images milla1cf Wed, 03/20/2024 - 19:16 March 20, 2024 — SARS-CoV-2 , the virus that causes COVID-19 , can damage the heart even without directly infecting the heart tissue, a National Institutes of Health -supported study has found.
105 
Becker's Hospital Review - Cardiology
OCTOBER 14, 2024
People who had a confirmed case of COVID-19 during the pandemic's first wave have twice the risk of heart attack, stroke and death compared to those who were never infected, according to research funded by the National Institutes of Health.
105 
Frontiers in Cardiovascular Medicine
NOVEMBER 25, 2024
Laboratory results revealed a rapidly progressing disseminated intravascular coagulation (“DIC”) and a clinically asymptomatic COVID-19 infection. Initial radiological imaging revealed no pathological findings. The patient died 38 h after admission due to a second-stage subarachnoid hemorrhage associated with progressive DIC.
59 
American College of Cardiology
JANUARY 24, 2025
In this weeks View, Dr. Eagle looks at left atrial appendage occlusion for stroke prevention in patients with AFib. Finally, Dr. Eagle explores anticoagulation for patients who are hospitalized with COVID-19. He then discusses a new treatment for severe hypertrophic cardiomyopathy in children.
58 
Science Daily - Stroke
AUGUST 13, 2024
The proposed imaging system can diagnose diabetes, stroke, anemia, asthma, liver and gallbladder conditions, COVID-19, and a range of vascular and gastrointestinal issues, according to new research. A computer algorithm has achieved a 98% accuracy in predicting different diseases by analyzing the color of the human tongue.
135 
Science Daily - Heart Disease
APRIL 3, 2024
Over the past three decades, reductions in death from leading killers fueled this progress, including diarrhea and lower respiratory infections, as well as stroke and ischemic heart disease. When the COVID-19 pandemic arrived in 2020, however, it derailed progress in many locations.
103 
Journal of Cardiothoracic Surgery
MARCH 24, 2025
This study compares sleep duration and stroke risk between residents of China and the U.S. during and outside the COVID-19 pandemic, examining age as an interaction effect.
52 
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP209-AWP209, February 1, 2025. Background:COVID-19, primarily a respiratory illness caused by SARS-CoV-2, is associated with vascular complications like ischemia due to endothelial injury, hypercoagulability, and inflammation. Demographics, clinical data, and outcomes are found in Table 1.
40 
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP268-AWP268, February 1, 2025. Introduction:The overall composition of stroke subtype is typically stable within biogeographical groups. Whether the COVID-19 pandemic impacted stroke etiology is still being investigated, but most studies have been performed outside the United States.
40 
DAIC
FEBRUARY 7, 2024
7-9, and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health. 7-9, and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health. Data was unavailable for the remaining 34 participants mainly due to the COVID-19 pandemic.
98 Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIn Australia, stroke is one of the leading causes of mortality, death, and disability (Kitsos et al., We also focused on inquiring about the disparities in access to stroke care for urban and rural regions in Australia.
40 
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIn Latin America and the Caribbean, stroke is the second greatest cause of both mortality and disability, with different incidence and prevalence rates across the regions due to regional and socioeconomic factors (Camargo et al.,
40 
Stroke Journal
DECEMBER 21, 2023
Stroke, Volume 55, Issue 1 , Page 78-88, January 1, 2024. BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. 1.51]; S-COVID, 2.10 [95% CI, 1.75–2.53]). versus 85.6%;P<0.001),
40 
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThe goal of this research project is to investigate the impacts and effects of the COVID‐19 pandemic on acute ischemic stroke treatment in North America.
40 
Medical Xpress - Cardiology
JANUARY 24, 2024
The continuing trend reverses improvements achieved in the decade before the COVID-19 pandemic to reduce mortalities from heart disease and stroke, the leading causes of death in the United States. The findings are reported in the American Journal of Preventive Medicine.
96 
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page A162-A162, February 1, 2025. Background:Preceding respiratory tract infections (RTIs) caused by bacteria or viruses are associated with worse stroke outcomes, likely due to an exaggerated inflammatory immune response, endothelial dysfunction, platelet activation, and coagulopathy. On day 6 (S.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page A112-A112, February 1, 2024. Introduction:The Vascular effects of Infection in Pediatric Stroke (VIPS II) study aimed to confirm prior findings that viral infection can trigger childhood arterial ischemic stroke (AIS). We defined the COVID-19 pandemic epoch as 1/2020-1/2022.
40 
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page A137-A137, February 1, 2025. Protocols for stroke management established by the American Heart Association (AHA) and American Stroke Association (ASA) include a 25-minute timeframe from door to CT time (DTCT). Patients presenting during COVID (OR 1.45; 95% CI 1.34-1.57)
40 Journal of the American Heart Association
JANUARY 31, 2024
BackgroundPatients with ischemic stroke and concomitant COVID‐19 infection have worse outcomes than those without this infection, but the impact of COVID‐19 on hemorrhagic stroke remains unclear. We aimed to assess if COVID‐19 worsens outcomes in intracerebral hemorrhage (ICH).Methods
40 Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThe coronavirus disease 2019 (COVID‐19) pandemic has had a global impact on healthcare systems. There is limited data on the influence of COVID‐19 on treatment and outcomes in patients with intracranial aneurysms.
40 
DAIC
FEBRUARY 1, 2024
International Stroke Conference 2024 to Present High-Profile Late-Breaking Science 6. Chung-Ang University Study Looks at Cardiovascular Risks in COVID-19 Survivors 8. Penumbra Launches Indigo System CAT RX Catheter in Europe to Address Acute Coronary Syndrome 4. In Memoriam: Bruce Wilkoff, MD, FHRS 5.
105 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP34-ATP34, February 1, 2024. Background:Hemorrhagic cerebrovascular manifestations are known to be associated with COVID-19. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. revealing an increase from pre-COVID 3.3
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP180-ATP180, February 1, 2024. Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP324-AWP324, February 1, 2024. COVID-19 neurological complications such as strokes and cognitive impairment have been reported. A mild and reproducible thromboembolic model will be a helpful tool for investigating COVID-thromboembolic complications.
40 Society of Thoracic Surgeons - Research
APRIL 12, 2021
A corporation known for its off-the-shelf cellular medicines approached CTSN, inviting researchers to help evaluate a cell therapy product and see if it could counteract inflammatory conditions related to COVID-19. The performance of the Network has been spectacular,” said Peter K.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP260-AWP260, February 1, 2024. Adult patients in 2018 (n=6,051,974) were compared to those in 2020 (n=5,470,813), the first year of the COVID-19 pandemic. To prevent potential confounding by undiagnosed COVID-19, patients in 2019 were not utilized in the analysis.
40 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page A58-A58, February 1, 2024. Multivariable logistic models were used to evaluate the differences in mortality between patients admitted from April to December 2020, with and without COVID-19, and those admitted during a similar period in 2019. 2.51; SAH: 2.76, 1.68-4.54), 4.16; SAH: 5.77, 1.57-21.17).
40 
DAIC
AUGUST 9, 2024
The American Stroke Association, a division of the American Heart Association. The American Stroke Association, a division of the American Heart Association. This study shows that people with stroke can also benefit from high-intensity interval training,” said Kevin Moncion, Ph.D., Click here to access the article.
52 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP52-AWP52, February 1, 2024. Background:Shortly after AHA/ASA released an updated policy on stroke care systems, COVID-19 disrupted these systems. As a result, telehealth expanded rapidly across Texas. Audiotapes were transcribed, and files prepared for analysis.
40 Journal of the American Heart Association
MARCH 21, 2025
We evaluated the association between social vulnerability and a composite of myocardial infarction, stroke, heart failure, venous thromboembolism, cardiogenic shock, cardiac arrest, and death, following discharge, using Cox regression models.
40 
DAIC
APRIL 11, 2024
The co-primary safety endpoint was designed to assess whether TAVR was non-inferior to SAVR as indicated by an absolute increase of no more than 1% in the composite rate of death or stroke at one year. In addition, the COVID-19 pandemic might have amplified the surgical risk.
111 
Circulation
JANUARY 16, 2024
During the COVID-19 pandemic, the American Heart Association created a new 2024 Impact Goal with health equity at its core, in recognition of the increasing health disparities in our country and the overwhelming evidence of the damaging effect of structural racism on cardiovascular and stroke health. Circulation, Ahead of Print.
Open Heart
JUNE 24, 2022
Introduction COVID-19 may lead to long-term endothelial consequences including hypertension, stroke and myocardial infarction. A pilot study ‘COVID-19 blood pressure endothelium interaction study’, which found that patients with normal blood pressure (BP) at the time of hospital admission with COVID-19 showed an 8.6
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content